Inactive Instrument

Exactus Inc Share Price OTC Bulletin Board

US30066P1021

Pharmaceuticals

End-of-day quote OTC Bulletin Board
- ^USD	-

18/11	Panacea Life Sciences Holdings and Benivita Inc. Launch Benivita PLSH	CI
06/24/06	Panacea Life Sciences Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Exactus, Inc. is a healthcare company. The Company is focused on manufacturing hemp derived Cannabidiol (CBD) products. It sells its CBD products through its Exactus brand and white label products to third-party resellers. It is also engaged in producing industrial hemp from farms in Oregon. Its products product line includes hemp flower, pre-rolled hemp flower, topicals, tinctures and concentrates. It also offers point-of-care diagnostic tools to analyze biometric markers in a drop of blood. Its FibriLyzer product provides solution to assess the fibrinolytic status of patients in a broad range of applications, including surgery, trauma, orthopedics, heart, stroke and chronic coronary disease management. Its MatriLyzer product detects the initial occurrence or the recurrence of cancer during routine office visits.

Employees

Sector

Pharmaceuticals

More about the company

LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!

SEIZE THE OFFER!

Market Cap	5L 5L 4L 4L 7L 4.98Cr 7L 51.19L 19.75L 2.53Cr 19.5L 19.06L 8.15Cr	P/E 2022	-0.11x	P/E 2023	-0.31x
Enterprise Value	2.2Cr 1.92Cr 1.82Cr 1.65Cr 3.09Cr 211.57Cr 3.1Cr 22Cr 8.39Cr 107.56Cr 8.28Cr 8.1Cr 346.1Cr	EV / Sales 2022	11.6x	EV / Sales 2023	10.1x
Free-Float	-	Yield 2022 *	-	Yield 2023	-

18/11	Panacea Life Sciences Holdings and Benivita Inc. Launch Benivita PLSH	CI
06/24/06	Panacea Life Sciences Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
01/24/01	Panacea Life Sciences Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
01/24/01	Panacea Life Sciences Holdings, Inc. Auditor Raises 'Going Concern' Doubt	CI
15/23/15	Panacea Life Sciences Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI
05/23/05	Panacea Life Sciences Holdings, Inc. completed the acquisition of N7 Enterprises, Inc.	CI
02/23/02	Panacea Life Sciences Holdings, Inc. entered into an Asset Purchase Agreement to acquire PÜR LIFE Medical, Inc.	CI
30/23/30	Panacea Life Sciences Holdings, Inc. completed the acquisition of Nitro Kava & Kratom from Gary Wilder, Lizard Juice, LLC, N7 Enterprises, Inc. and New Age Distribution Corp. for $7.8 million.	CI
15/23/15	Panacea Life Sciences Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	CI
02/23/02	Panacea Life Sciences Holdings, Inc. entered into a non-binding LOI to acquire Sierra Sages Herbs, LLC and Halucenex Life Sciences Inc. for $20 million.	CI
10/23/10	Panacea Life Sciences Holdings, Inc. agreed to acquire Nitro Kava & Kratom.	CI
10/23/10	Panacea Life Sciences Holdings, Inc. entered into agreements acquire 8 Retail Locations in the Tampa, Florida.	CI
15/23/15	Panacea Life Sciences Holdings, Inc. Distribution Division Signs Exclusive Distribution Agreement with QR Joy to Distribute U.S. Top Fume Disposable Vape Devices in the U.K	CI

18/11	Panacea Life Sciences Holdings (OTCID: PLSH) and Benivita Inc. Launch Benivita PLSH -- a New Era in Direct-to-Consumer Virtual Benefits	PR
16/24/16	Panacea Life Sciences and Sky Wellness Enter Agreement for Licensing, Marketing, Supply and Development of Sky Wellness CBD Products	AQ
16/24/16	Panacea Life Sciences : and Sky Wellness Enter Agreement for Licensing, Marketing, Supply and Development of Sky Wellness CBD Products - Form 8-K	PU
05/23/05	Panacea Life Sciences Holdings, Inc. Completes Acquisition of N7 Enterprises With Eight Natural Health and Wellness Retail and One Distribution Center Locations in the Tampa, Florida area	AQ
02/23/02	Panacea Life Sciences Holdings, Inc. Continues Growth Trajectory with Acquisition of the PÜR LIFE Medical Franchise	AQ

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
ELI LILLY AND COMPANY	+0.04%	+3.34%	+51.12%	+101.82%	1,02800Cr
JOHNSON & JOHNSON	-0.09%	+1.66%	+55.02%	+66.18%	65TCr
ABBVIE INC.	-0.02%	+2.66%	+18.91%	+71.47%	47TCr
ROCHE HOLDING AG	-1.22%	+3.66%	+36.44%	+38.32%	35TCr
NOVARTIS AG	-0.79%	+2.73%	+19.03%	+25.08%	27TCr
ASTRAZENECA PLC	+0.58%	+6.76%	+11.13%	+16.52%	26TCr
AMGEN INC.	+1.55%	+2.20%	+39.81%	+46.55%	21TCr
NOVO NORDISK A/S	+0.79%	+1.84%	-28.27%	-56.71%	19TCr
GILEAD SCIENCES, INC.	-0.52%	+4.45%	+32.12%	+98.51%	19TCr
Average	+0.20%	+3.26%	+26.15%	+45.30%	40.02TCr
Weighted average by Cap.	+0.23%	+3.09%	+35.15%	+61.76%

	2022	2023
Net sales	16.27L 14.19L 13.4L 12.16L 22.79L 16Cr 22.89L 1.6Cr 61.92L 7.94Cr 61.12L 59.76L 26Cr	23.85L 20.8L 19.64L 17.83L 33.41L 23Cr 33.55L 2.35Cr 90.77L 12Cr 89.59L 87.6L 37Cr
Net income	-91.43L -79.72L -75.28L -68.36L -1.28Cr -88Cr -1.29Cr -9.02Cr -3.48Cr -45Cr -3.43Cr -3.36Cr -143.51Cr	-80.15L -69.89L -66L -59.93L -1.12Cr -77Cr -1.13Cr -7.91Cr -3.05Cr -39Cr -3.01Cr -2.94Cr -125.82Cr
Net Debt	1.79Cr 1.56Cr 1.47Cr 1.33Cr 2.5Cr 171.31Cr 2.51Cr 18Cr 6.8Cr 87Cr 6.71Cr 6.56Cr 280.25Cr	2.15Cr 1.88Cr 1.77Cr 1.61Cr 3.02Cr 206.59Cr 3.03Cr 21Cr 8.19Cr 105.03Cr 8.09Cr 7.91Cr 337.95Cr

Exactus Inc Share Price OTC Bulletin Board

Stocks

US30066P1021

Pharmaceuticals

Valuation: Exactus Inc

Latest news: Exactus Inc

Press Releases: Exactus Inc

Other Pharmaceuticals

Financials

Company Profile